Published in J Neuroinflammation on October 31, 2014
Activation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome. J Neuroinflammation (2016) 0.77
Mast cells in meningiomas and brain inflammation. J Neuroinflammation (2015) 0.76
Selective serotonin reuptake inhibitor combined with dengzhanshengmai capsule improves the fatigue symptoms: a 12-week open-label pilot study. Int J Clin Exp Med (2015) 0.75
Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol (2001) 18.80
Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74
Toll-like receptors in the induction of the innate immune response. Nature (2000) 12.23
The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med (2006) 10.99
AP-1 as a regulator of cell life and death. Nat Cell Biol (2002) 10.10
The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev (2000) 8.92
AP-1 subunits: quarrel and harmony among siblings. J Cell Sci (2004) 5.08
Chemokines: multiple levels of leukocyte migration control. Trends Immunol (2004) 3.32
Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol (2011) 2.92
Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol (2000) 2.64
Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med (2008) 2.48
Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev (2008) 2.39
Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol (2004) 2.02
Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol (2004) 1.98
Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol (2006) 1.97
Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol (2009) 1.94
Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4. Nat Immunol (2003) 1.69
TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol (2004) 1.61
Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol (2005) 1.58
Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med (2004) 1.57
Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci (2004) 1.50
Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol (2005) 1.45
Chronic fatigue syndrome, mast cells, and tricyclic antidepressants. J Clin Psychopharmacol (2005) 1.44
Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc Natl Acad Sci U S A (2008) 1.42
TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood (2005) 1.39
Flavonoids and the CNS. Molecules (2011) 1.37
Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics (2009) 1.34
Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord (2011) 1.30
Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch Pharm Res (2008) 1.28
Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. Endocrinology (1995) 1.24
Fatigue and chronic fatigue syndrome-like complaints in the general population. Eur J Public Health (2009) 1.24
Innate immunity and its regulation by mast cells. J Immunol (2013) 1.19
Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo. Brain Res (1999) 1.19
Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J (2012) 1.18
Dietary flavonoids: Role of (-)-epicatechin and related procyanidins in cell signaling. Free Radic Biol Med (2011) 1.16
Chronic fatigue syndrome: the need for subtypes. Neuropsychol Rev (2005) 1.14
Brain cytokines and neuropsychiatric disorders. J Clin Psychopharmacol (2004) 1.14
Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. Free Radic Biol Med (2011) 1.13
Targeting chemokine receptors in chronic inflammatory diseases: an extensive review. Pharmacol Ther (2011) 1.13
TNF-alpha transgenic and knockout models of CNS inflammation and degeneration. J Neuroimmunol (1997) 1.13
Biomarkers for chronic fatigue. Brain Behav Immun (2012) 1.13
Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Pract Res Clin Rheumatol (2003) 1.12
TLR signaling in mast cells: common and unique features. Front Immunol (2012) 1.12
Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc Natl Acad Sci U S A (2006) 1.10
Flavonoids and cognitive function: a review of human randomized controlled trial studies and recommendations for future studies. Genes Nutr (2009) 1.09
Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun (2011) 1.08
Curcumin, a polyphenolic antioxidant, attenuates chronic fatigue syndrome in murine water immersion stress model. Immunobiology (2008) 1.08
Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol Biochem Behav (2003) 1.06
Stem cell factor and igE-stimulated murine mast cells produce chemokines (CCL2, CCL17, CCL22) and express chemokine receptors. Inflamm Res (2001) 1.06
Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Res Bull (2007) 1.05
The mast cell: a neuroimmunoendocrine master player. Int J Tissue React (1996) 1.05
Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study. Fertil Steril (2006) 1.04
Genistein suppresses LPS-induced inflammatory response through inhibiting NF-κB following AMP kinase activation in RAW 264.7 macrophages. PLoS One (2012) 1.03
Corticotropin-releasing hormone and the blood-brain-barrier. Front Biosci (2007) 1.01
Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells. Br J Pharmacol (2008) 1.01
Comparative study of anxiety, depression, somatization, functional disability, and illness attribution in adolescents with chronic fatigue or migraine. Pediatrics (2003) 1.00
A review and meta-synthesis of qualitative studies on myalgic encephalomyelitis/chronic fatigue syndrome. Patient Educ Couns (2011) 1.00
Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies. J Clin Rheumatol (2014) 0.99
Epigallocatechin-3-gallate inhibits secretion of TNF-alpha, IL-6 and IL-8 through the attenuation of ERK and NF-kappaB in HMC-1 cells. Int Arch Allergy Immunol (2006) 0.99
Target-based selection of flavonoids for neurodegenerative disorders. Trends Pharmacol Sci (2012) 0.98
Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin Rheumatol (2010) 0.97
Human mast cells release Interleukin-8 and induce neutrophil chemotaxis on contact with activated T cells. Allergy (2005) 0.96
FcεR1-mediated mast cell reactivity is amplified through prolonged Toll-like receptor-ligand treatment. PLoS One (2012) 0.95
Mouse running activity is lowered by Brucella abortus treatment: a potential model to study chronic fatigue. Physiol Behav (1998) 0.94
Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients. In Vivo (2009) 0.94
Astragalus membranaceus flavonoids (AMF) ameliorate chronic fatigue syndrome induced by food intake restriction plus forced swimming. J Ethnopharmacol (2008) 0.94
Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab (2001) 0.92
Chronic fatigue syndrome: understanding a complex illness. Nat Rev Neurosci (2011) 0.91
Chemokine receptor expression by mast cells. Chem Immunol Allergy (2005) 0.91
Central nervous system abnormalities in fibromyalgia and chronic fatigue syndrome: new concepts in treatment. Curr Pharm Des (2008) 0.90
Anxiety in children with CFS/ME. Eur Child Adolesc Psychiatry (2009) 0.90
Dermal IgG deposits and increase of mast cells in patients with fibromyalgia--relevant findings or epiphenomena? Scand J Rheumatol (1997) 0.90
Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions. Neuroscience (1997) 0.90
Mast cells as effector cells: a co-stimulating question. Trends Immunol (2007) 0.90
Fibromyalgia syndrome: an overview of pathophysiology, diagnosis and management. Oman Med J (2012) 0.88
Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Psychother Psychosom (2012) 0.87
A systematic review of chronic fatigue syndrome: don't assume it's depression. Prim Care Companion J Clin Psychiatry (2008) 0.87
Is chronic fatigue syndrome the same illness as fibromyalgia: evaluating the 'single syndrome' hypothesis. QJM (2012) 0.86
Quercetin protects against acute immobilization stress-induced behaviors and biochemical alterations in mice. J Med Food (2008) 0.84
Mast cell-derived cytokine expression induced via Fc receptors and Toll-like receptors. Chem Immunol Allergy (2005) 0.84
Possible role for early-life immune insult including developmental immunotoxicity in chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME). Toxicology (2008) 0.83
Polyphenols differentially inhibit degranulation of distinct subsets of vesicles in mast cells by specific interaction with granule-type-dependent SNARE complexes. Biochem J (2013) 0.83
Luteolin and thiosalicylate inhibit HgCl(2) and thimerosal-induced VEGF release from human mast cells. Int J Immunopathol Pharmacol (2011) 0.83
Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants. Expert Opin Pharmacother (2009) 0.83
Monoamine oxidase A expression is suppressed in human cholangiocarcinoma via coordinated epigenetic and IL-6-driven events. Lab Invest (2012) 0.82
Possible involvement of TLRs and hemichannels in stress-induced CNS dysfunction via mastocytes, and glia activation. Mediators Inflamm (2013) 0.81
Epigallocatechin-3-gallate inhibits mast cell degranulation, leukotriene C4 secretion, and calcium influx via mitochondrial calcium dysfunction. Free Radic Biol Med (2010) 0.81
Evidence that brain mast cells can modulate neuroinflammatory responses by tumour necrosis factor-alpha production. Neuroreport (1998) 0.81
Modulation of antigen-induced chronic fatigue in mouse model of water immersion stress by naringin, a polyphenolic antioxidant. Fundam Clin Pharmacol (2009) 0.81
Fibromyalgia and other unexplained clinical conditions. Curr Rheumatol Rep (2001) 0.80
Decreased mitochondrial function and increased brain inflammation in bipolar disorder and other neuropsychiatric diseases. J Clin Psychopharmacol (2011) 0.80
Epigallocatechin gallate ameliorates behavioral and biochemical deficits in rat model of load-induced chronic fatigue syndrome. Brain Res Bull (2011) 0.80
Atopic conditions in search of pathogenesis and therapy. Clin Ther (2013) 0.80
Endogenous neurotensin regulates hypothalamic-pituitary-adrenal axis activity and peptidergic neurons in the rat hypothalamic paraventricular nucleus. J Neuroendocrinol (1997) 0.79
Protective effect of epigallocatechin gallate in murine water-immersion stress model of chronic fatigue syndrome. Basic Clin Pharmacol Toxicol (2010) 0.79
Intracellular RNA recognition pathway activates strong anti-viral response in human mast cells. Clin Exp Immunol (2013) 0.79
Possible role of oxidative stress and immunological activation in mouse model of chronic fatigue syndrome and its attenuation by olive extract. J Neuroimmunol (2010) 0.79
Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats. J Ethnopharmacol (2012) 0.78
Influence of immediate hypersensitivity skin reactions on delayed reactions in patients with chronic fatigue syndrome. J Allergy Clin Immunol (1996) 0.78